Brief: Kancera To Seek Stakeholders For Reverse Take Over

Novakand Pharma AB

19/09/2025 07:42

Sept 19 (Reuters) - Kancera AB KANC.ST:

SAID ON THURSDAY KANCERA INITIATES PROCESS TO SEEK STAKEHOLDERS FOR REVERSE TAKE OVER

AIM IS TO MATERIALIZE VALUE OF CO'S PUBLIC LISTING

OPPORTUNITIES TO RAISE SUFFICIENT AMOUNT OF EXTERNAL CAPITAL NEAR-TERM IS PERCEIVED TO BE LOW

SURVIVAL OF COMPANY IS PERCEIVED TO BE AT RISK, IF SIGNIFICANT MEASURES ARE NOT TAKEN

IF THERE IS LACK OF STRATEGIC OPTIONS, BOARD’S INTENTION IS TO RECOMMEND DE-LISTING FROM NASDAQ FIRST NORTH GROWTH MARKET AND VOLUNTARY LIQUIDATION

DECISION TO EXECUTE A POTENTIAL REVERSE TAKE OVER, DE-LISTING OR LIQUIDATION WILL BE TAKEN AT FUTURE GENERAL MEETING

 Source text for Workspace: nMFN5V9nHF
 Further company coverage: KANC.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))